DAYVIGO
lemborexant
- Strength
- 5 mg/1
- Form
- Tablet, Film Coated
- Class
- Orexin Receptor Antagonist
Eisai Inc.
Not stocked by us — reference only
lemborexant
Listed by Eisai Inc.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Orexin Receptor Antagonist |
| Approval route | NDA — original brand approval |
| NDC code | 62856-410 |
| FDA application | NDA212028 |
| RxNorm concept | 2272408 |
| Package sizes listed | 2 |
| Marketed since | April 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
lemborexant
Eisai Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.